High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator (Q47879726)

6 February 2018

title

High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator (English)

1 reference

6 February 2018

main subject

interleukins

0 references

author name string

Victoria Rotter Sopasakis

1

1 reference

6 February 2018

Madeléne Sandqvist

2

1 reference

6 February 2018

Birgit Gustafson

3

1 reference

6 February 2018

Ann Hammarstedt

4

1 reference

6 February 2018

Martin Schmelz

5

1 reference

6 February 2018

Xiaolin Yang

6

1 reference

6 February 2018

Per-Anders Jansson

7

1 reference

6 February 2018

Ulf Smith

8

1 reference

6 February 2018

publication date

1 March 2004

1 reference

6 February 2018

published in

Obesity

1 reference

6 February 2018

volume

12

1 reference

6 February 2018

issue

3

1 reference

6 February 2018

page(s)

454-460

1 reference

6 February 2018

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Insulin acutely increases fibrinogen production in individuals with type 2 diabetes but not in individuals without diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Is type II diabetes mellitus a disease of the innate immune system?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

31 March 2020

The acute phase response

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Association between adiponectin and mediators of inflammation in obese women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

The hormone resistin links obesity to diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Resistin and obesity-associated insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Relation of body fat distribution to metabolic complications of obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Glycerol production in subcutaneous adipose tissue in lean and obese humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Plasma extravasation and neuropeptide release in human skin as measured by intradermal microdialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Validation of an endogenous reference technique for the calibration of microdialysis catheters

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Delayed transcapillary transport of insulin to muscle interstitial fluid in obese subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Measurement by microdialysis of the insulin concentration in subcutaneous interstitial fluid. Importance of the endothelial barrier for insulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Lactate metabolism of subcutaneous adipose tissue studied by open flow microperfusion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Muscle-derived interleukin-6: possible biological effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Adipose tissue fat cell size and number in relation to metabolism in randomly selected middle-aged men and women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Relationship of visceral adipose tissue to metabolic risk factors for coronary heart disease: is there a contribution of subcutaneous fat cell hypertrophy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Hyperleptinemia is more closely associated with adipose cell hypertrophy than with adipose tissue hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Failure of adipocyte differentiation causes type II diabetes mellitus?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

Adiponectin gene activation by thiazolidinediones requires PPAR gamma 2, but not C/EBP alpha-evidence for differential regulation of the aP2 and adiponectin genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.51

31 March 2020

Identifiers

DOI

10.1038/OBY.2004.51

1 reference

6 February 2018

1 reference

6 February 2018